Core Viewpoint - Janus Living, Inc. has successfully closed a new $500 million unsecured revolving credit facility and a $100 million unsecured delayed-draw term loan facility, enhancing its financial flexibility and capacity for growth [1] Group 1: Credit Facility Details - The Revolving Facility allows for borrowing up to $500 million and is set to mature in March 2030 [1] - The Term Loan amounts to $100 million and is part of the overall Credit Facility [1]

Core Viewpoint - Janus Living has successfully completed its initial public offering (IPO) of 48,300,000 shares of Class A-1 common stock at a public price of $20.00 per share, raising approximately $878 million in net proceeds for investment opportunities and corporate purposes [1][2]. Group 1: IPO Details - The IPO included the full exercise of the underwriters' option to purchase an additional 6,300,000 shares [1]. - Shares of Janus Living began trading on the New York Stock Exchange under the ticker symbol "JAN" on March 20, 2026 [2]. - The net proceeds from the offering will be used for acquisition and investment opportunities that align with Janus Living's investment criteria [2]. Group 2: Underwriters and Management - BofA Securities and J.P. Morgan served as lead book-running managers for the offering, with several other financial institutions acting as bookrunners and co-managers [3]. - The offering was conducted under a prospectus, and copies of the final prospectus can be obtained from the lead underwriters [4]. Group 3: Company Background - Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) focused on healthcare real estate [6]. - Janus Living, Inc. is a senior housing REIT that owns high-quality communities across the United States [7].

Core Insights - Janus Living, Inc. is a newly established pure-play senior housing REIT, spun off from Healthpeak Properties to capitalize on the growing senior housing market driven by demographic trends [2][3] - The IPO is set to price at $20 per share, raising approximately $840 million through the sale of 42 million shares, which was upsized from an initial offering of 37 million shares [3][5] - Healthpeak Properties will retain a significant economic interest of approximately 83.6% post-IPO, indicating continued influence over Janus Living [5] Company Overview - Janus Living focuses on owning and operating high-quality senior living communities across the United States, emphasizing well-designed and amenitized environments for residents [2] - The company is structured under RIDEA, which allows for operational flexibility and aligns with its focus on senior housing [2] IPO Details - The IPO is scheduled for March 17, 2026, with the pricing finalized on March 19, 2026, aimed at funding acquisitions and investments in senior housing properties [3][4] - Underwriters have a 30-day option to purchase up to an additional 6.3 million shares to cover overallotments, enhancing the financial flexibility of Janus Living [5] Market Context - The IPO reflects strong investor interest in the senior housing sector, particularly as the population ages, positioning Janus Living as the only public pure-play senior housing REIT in the U.S. [4]

Company Overview - Janus Living, a senior housing-focused real estate investment trust (REIT), achieved a valuation of $5.92 billion following a 17.5% increase in its share price during its debut on the New York Stock Exchange (NYSE) [1] - The company operates 34 senior housing communities across 10 states, with a primary focus on Florida and Texas, and aims to generate rental income from senior housing while benefiting from the growth driven by aging demographics [3] IPO Details - Janus Living's shares opened at $23.50, exceeding the offer price of $20 per share, and the company raised $840 million in its upsized U.S. initial public offering by selling 42 million shares at the top end of its marketed range of $18 to $20 [2] - The U.S. IPO market has faced volatility, leading to several listings being postponed or withdrawn, yet there remains strong investor interest in companies that are less exposed to broader market fluctuations and insulated from AI disruption [2]

Core Insights - The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the trading floor [1] Group 1 - The advisory is issued on March 20, 2026, indicating the NYSE's commitment to transparency and timely information dissemination [1]

Core Viewpoint - Healthpeak (DOC) is undervalued in the market, particularly regarding its senior housing assets, which are being spun off into a new entity, Janus Living (JAN), to unlock their true value [1][2][29]. Valuation Overview - Healthpeak's property valuation includes $10.5 billion in medical office buildings (MOBs), $8.8 billion in labs, and approximately $3 billion in senior housing [3]. - The senior housing portfolio is believed to be worth $4.25 billion, significantly higher than the $3 billion recorded on the books [2][12]. Market Comparisons - The market multiples for different property sectors show that labs trade at the lowest multiples, while senior housing commands the highest [5][8]. - Healthpeak trades at 11.3X AFFO, which is between the multiples for labs (10.3X) and MOBs (14.6X), indicating a lack of recognition for its senior housing assets [8][11]. Upcoming IPO Details - The IPO for Janus Living is targeting a price range of $18-$20 per share, with strong investor interest already indicated [13][14]. - The offering aims to raise approximately $635.5 million in net proceeds, with Healthpeak retaining a significant ownership stake in Janus [15][17]. Financial Metrics - The implied valuation of Janus at the midpoint offering price of $19 suggests a total value of approximately $4.79 billion, with senior housing assets valued at around $4.26 billion after accounting for cash and debt [19][21]. - The pro forma estimated NOI for the senior housing portfolio is $199.6 million, with an AFFO of $170 million [25]. Future Growth Potential - Janus Living is expected to utilize IPO proceeds for immediate acquisitions, positioning it for growth [30]. - Healthpeak will benefit from the value appreciation of Janus shares, which will be held on its balance sheet for at least a year due to lock-up provisions [32].

Core Insights - Healthpeak Properties, Inc. announced the IPO of its senior housing REIT, Janus Living, offering 37 million shares priced between $18 and $20 per share [1][2] Group 1: IPO Details - Janus Living plans to offer underwriters a 30-day option to purchase an additional 5,550,000 shares to cover overallotments [2] - The Class A-1 common stock will be listed on the New York Stock Exchange under the ticker "JAN" [2] Group 2: Use of Proceeds - The net proceeds from the IPO will be used for acquisitions, investment opportunities, and general corporate needs [3] - Healthpeak will retain approximately 85.3% economic interest in Janus Living post-IPO, which could decrease to 83.4% if underwriters fully exercise their option [3] Group 3: Company Background - Healthpeak spun out its senior housing assets into Janus Living in early 2026 to unlock value through the IPO [4] - Janus Living manages a portfolio of 34 communities with 10,422 units across 10 states, focusing on high-demand markets like Florida and Texas [4] - Healthpeak serves as the external manager for Janus Living, earning an annual fee of $10 million [4] Group 4: Market Performance - In the past month, shares of Healthpeak have increased by 3.5%, while the industry has declined by 1.3% [4]

Core Viewpoint - Janus Living has launched its initial public offering (IPO) of 37 million Class A-1 shares, with an expected price range of $18 to $20 per share [1][2]. Group 1: IPO Details - The offering includes a 30-day option for underwriters to purchase an additional 5.5 million Class A-1 shares to cover overallotments [1]. - Janus Living plans to list its shares on the New York Stock Exchange under the ticker "JAN" [2]. Group 2: Use of Proceeds - The net proceeds from the IPO will be utilized for acquisitions, investment opportunities, and general corporate purposes [2]. Group 3: Ownership Structure - Post-IPO, Healthpeak Properties will own approximately 214.73 million shares of Janus Living Class A-1 common stock, representing about 85.3% economic interest in the company [2]. Group 4: Underwriters - BofA Securities and J.P. Morgan are serving as lead book-running managers for the offering [3]. Group 5: Market Performance - Healthpeak shares closed at $16.98, reflecting a 0.47% increase [3].

Core Viewpoint - Janus Living, Inc. has launched its initial public offering (IPO) of 37 million shares of Class A-1 common stock, with an expected price range of $18.00 to $20.00 per share, aiming to raise capital for acquisitions and general corporate purposes [1][12]. Group 1: IPO Details - The IPO will consist of 37,000,000 shares of Class A-1 common stock, with an expected price range of $18.00 to $20.00 per share [1]. - Janus Living plans to grant underwriters a 30-day option to purchase an additional 5,550,000 shares to cover overallotments [1]. - The shares are expected to be listed on the New York Stock Exchange under the symbol "JAN" [1]. Group 2: Ownership Structure - After the IPO, Healthpeak Properties will own approximately 214,734,000 shares of Janus Living Class A-1 common stock and common units, representing an 85.3% economic interest in Janus Living, which will decrease to 83.4% if the underwriters' option is fully exercised [2]. Group 3: Underwriters - BofA Securities and J.P. Morgan are the lead book-running managers for the offering, with several other financial institutions acting as bookrunners and co-managers [3].

Core Insights - Donovan Jones is an IPO research specialist with 15 years of experience analyzing investment opportunities for U.S. IPOs [1] - He leads the investing group IPO Edge, which provides actionable information on growth stocks through various resources [1] Group 1 - IPO Edge offers first-look IPO filings, previews on upcoming IPOs, an IPO calendar, a database of U.S. IPOs, and a guide to IPO investing [1] - The guide walks investors through the entire IPO lifecycle, including filing, listing, quiet period, and lockup expiration dates [1]